Skip to main content

Table 3 UM patients characteristics

From: Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma

Code LB

Sex

Age (Y)

Location

ctDNA

FA

Lesion

T category, AJCC classification

FU

Rx

21

F

70

Choroid

4.3

9.5

3 × 10 × 9

2

77

P

22

F

60

Choroid

2.8

3.7

9 × 1.9 × 5.7

4

50

P

27

F

68

Choroid

3.0

8

9.7  × 9  × 3.3

2

39

P+

28

F

48

Choroid

1.9

2.8

7.5 × 5.5 × 2.1

1

260

TT

29

M

62

Iris

12.8

2.7

3.4 × 3.8 × 1.3

1

37

PR

30

M

69

Choroid

2.3

17

16 × 16 × 8

3

61

P+

31

M

85

Choroid

29.3

33

9.5 × 8.5 × 3.1

3

229

P

32

M

63

Choroid

2.1

2.6

11.5 × 12 × 2.8

1

190

P+

33

F

82

Choroid

26.4

7

2.2 × 1 × 1

2

37

P+

36

M

37

Choroid

31.6

3.1

13.3 × 10.9 × 5

2

1

P

40

F

38

Choroid

3.2

1.6

10.7 × 8.5 × 3.0

1

92

SR

41

M

71

Choroid

9.8

13.5

8.2 × 8.7 × 4.3

2

164

P

42

F

38

Choroid

0.7

4

13 × 9.5 × 2.3

2

55

P+

43

M

51

Choroid

9.0

5

8.4 × 9.1 × 2.8

1

150

P

  1. + = anti-VEGF treatment; AJCC AJCC classification; ctDNA (molecules/ml); FA percentage of fractional abundance; FU follow-up time (months); Lesion Lesion size (small diameter x large diameter x thickness) (in mm); P Plaque radiotherapy; PR Proton beam radiotherapy; Rx Treatment; SR Stereotactic radiosurgery; T T category; TT Transpupillary thermotherapy